Nestlé is issuing a recall of specific batches of infant formula, primarily in Europe, due to potential contamination with a toxin that could lead to symptoms like nausea and vomiting. However, the recall does not involve any products in Canada, as confirmed by the company.
The company has decided to voluntarily recall certain products, including batches of SMA, BEBA, and NAN infant formulas, as a precautionary step due to concerns about the potential presence of a toxin known as cereulide in these batches. Cereulide is a toxin produced by a specific type of bacteria, capable of causing food poisoning and resulting in severe vomiting and nausea for up to 24 hours, as highlighted by Ireland’s food inspection agency, one of the impacted countries.
Nestlé emphasized its commitment to the safety and well-being of infants in a recall notice on its website, stating that the recall is a proactive measure in alignment with their stringent product quality and safety standards. The company conducted testing on its products following a quality issue in an ingredient sourced from a supplier. Nestlé confirmed that no illnesses related to the recalled products have been reported.
The recall affects several countries, including Turkey, Argentina, the U.K., Ireland, and various European nations, but Nestlé has assured that there is no impact on products in Canada. The Canadian Food Inspection Agency (CFIA) also confirmed that there has been no distribution of the affected formulas in Canada. The CFIA stated that they would promptly inform the public if any Canadian products are found to be affected.
Nestlé has shared a list of affected batch numbers online, advising consumers to check the bottom of the formula tins or boxes for the batch codes. Consumers who have purchased the affected formulas are urged not to use them and to contact Nestlé for a refund.
Austria’s health ministry disclosed that the recall impacted over 800 products from more than 10 Nestlé factories, marking the largest recall in the company’s history. The reported figures have not been officially verified by Nestlé. Nestlé, a Swiss multinational company, controls a significant share of the global infant nutrition market and has been under pressure following the recall, leading to a decline in its shares.
The recall, which initially started on a smaller scale in December, is adding challenges for Philipp Navratil, Nestlé’s new chief executive, who is focusing on revitalizing growth through a comprehensive portfolio review following a period of management changes.